SRE · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $12.42B | $11.82B | $14.85B | $13.72B | $11.68B | $10.31B | $10.14B | $9.45B |
| Interest Expense | — | — | $1.31B | $1.05B | $1.20B | $1.08B | $1.08B | $886.00M |
| Other Income / (Expense) | $169.00M | $136.00M | $131.00M | $24.00M | $58.00M | -$48.00M | $77.00M | $72.00M |
| Income Before Taxes | $1.79B | $2.71B | $3.26B | $2.01B | $833.00M | $1.78B | $1.76B | $478.00M |
| Provision for Income Taxes | $701.00M | $219.00M | $490.00M | $556.00M | $99.00M | $249.00M | $315.00M | -$49.00M |
| Net Income | $1.84B | $2.86B | $3.08B | $2.14B | $1.32B | $4.11B | $2.36B | $1.13B |
| Basic EPS | $2.75 | $4.44 | $4.81 | $3.32 | $2.01 | $12.93 | $7.40 | $3.45 |
| Diluted EPS | $2.75 | $4.42 | $4.79 | $3.31 | $2.01 | $12.88 | $7.29 | $3.42 |
| Basic Shares Outstanding | 652.70M | 633.79M | 630.30M | 630.32M | 623.51M | 291.08M | 277.90M | 268.07M |
| Diluted Shares Outstanding | 653.83M | 637.94M | 632.73M | 632.76M | 626.07M | 292.25M | 282.03M | 269.85M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $5.12 | $5.05 | $5.21 | 10 | ↑3 ↓0 |
| Dec 2027 | $5.52 | $5.40 | $5.66 | 10 | ↑0 ↓1 |
| Dec 2028 | $6.00 | $5.88 | $6.18 | 5 | ↑0 ↓0 |
| Dec 2029 | $6.64 | $6.46 | $6.81 | 2 | ↑1 ↓0 |